Last updated: 9 March 2022 at 4:55pm EST

Todd C. Longsworth Net Worth




The estimated Net Worth of Todd Christopher Longsworth is at least 14.9 百万$ dollars as of 8 March 2022. Mr Longsworth owns over 2,339 units of NovoCure Ltd stock worth over 1,076,220$ and over the last 8 years he sold NVCR stock worth over 12,661,533$. In addition, he makes 1,154,239$ as Gen. Counsel at NovoCure Ltd.

Mr Longsworth NVCR stock SEC Form 4 insiders trading

Mr has made over 18 trades of the NovoCure Ltd stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 2,339 units of NVCR stock worth 163,964$ on 8 March 2022.

The largest trade he's ever made was exercising 158,440 units of NovoCure Ltd stock on 3 September 2019 worth over 1,527,362$. On average, Mr trades about 12,522 units every 48 days since 2017. As of 8 March 2022 he still owns at least 62,462 units of NovoCure Ltd stock.

You can see the complete history of Mr Longsworth stock trades at the bottom of the page.





Mr. Todd C. Longsworth biography

Todd C. Longsworth is the Gen. Counsel at NovoCure Ltd.

What is the salary of Mr Longsworth?

As the Gen. Counsel of NovoCure Ltd, the total compensation of Mr Longsworth at NovoCure Ltd is 1,154,239$. There are 8 executives at NovoCure Ltd getting paid more, with William Doyle having the highest compensation of 8,286,100$.



How old is Mr Longsworth?

Mr Longsworth is 46, he's been the Gen. Counsel of NovoCure Ltd since . There are 19 older and 5 younger executives at NovoCure Ltd. The oldest executive at NovoCure Ltd is Prof. Yoram Palti, 83, who is the Founder & CTO.

What's Mr Longsworth's mailing address?

Todd's mailing address filed with the SEC is C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300, MALVERN, PA, 19355.

Insiders trading at NovoCure Ltd

Over the last 9 years, insiders at NovoCure Ltd have traded over 237,132,855$ worth of NovoCure Ltd stock and bought 164,174 units worth 2,198,429$ . The most active insiders traders include Asaf DanzigerWilliam Fwfd Ventures Fund ...Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of 853,350$. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth 13,856$.



What does NovoCure Ltd do?

we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.



What does NovoCure Ltd's logo look like?

NovoCure Ltd logo

Complete history of Mr Longsworth stock trades at NovoCure Ltd

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
8 Mar 2022 Todd Christopher Longsworth
ゼネラルカウンセル
販売 2,339 70.10$ 163,964$
8 Mar 2022
62,462
3 Mar 2022 Todd Christopher Longsworth
ゼネラルカウンセル
販売 3,067 71.87$ 220,425$
3 Mar 2022
64,801
8 Mar 2021 Todd Christopher Longsworth
ゼネラルカウンセル
販売 2,404 130.81$ 314,467$
8 Mar 2021
67,714
4 Mar 2021 Todd Christopher Longsworth
ゼネラルカウンセル
販売 3,084 137.55$ 424,204$
4 Mar 2021
70,118
2 Mar 2021 Todd Christopher Longsworth
ゼネラルカウンセル
販売 2,355 152.05$ 358,078$
2 Mar 2021
62,860
27 Feb 2021 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 5,555 149.10$ 828,251$
27 Feb 2021
65,215
15 Jan 2021 Todd Christopher Longsworth
ゼネラルカウンセル
販売 63,814 172.48$ 11,006,639$
15 Jan 2021
59,660
6 Mar 2020 Todd Christopher Longsworth
ゼネラルカウンセル
販売 2,499 69.53$ 173,755$
6 Mar 2020
86,753
27 Feb 2020 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 5,556 79.45$ 441,424$
27 Feb 2020
72,675
24 Feb 2020 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 21,666 88.26$ 1,912,241$
24 Feb 2020
75,601
3 Sep 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 158,440 9.64$ 1,527,362$
3 Sep 2019
84,314
27 Feb 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 5,556 52.90$ 293,912$
27 Feb 2019
39,203
22 Feb 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 21,667 53.38$ 1,156,584$
22 Feb 2019
42,972
24 Jan 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 26,874 7.15$ 192,149$
24 Jan 2019
33,179
16 Jan 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 15,000 7.15$ 107,250$
16 Jan 2019
36,305
9 Jan 2019 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 15,000 7.15$ 107,250$
9 Jan 2019
36,305
22 Feb 2018 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 21,667 21.55$ 466,924$
22 Feb 2018
26,665
29 Jan 2018 Todd Christopher Longsworth
ゼネラルカウンセル
オプション行使 11,630 6.72$ 78,154$
29 Jan 2018
16,628


NovoCure Ltd executives and stock owners

NovoCure Ltd executives and other stock owners filed with the SEC include: